Portfolio company
Applied Biotherapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops platform technologies for delivering low-dose radiation precisely at tumor margins for cancer patients undergoing surgical removal.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GT Medical Technologies
This company produces bioresorbable radiotherapy implants for patients with operable brain tumors to deliver targeted radiation immediately following surgical removal.
Alpha-9 Theranostics
This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.
Actithera Group
This company develops radioligand therapies to treat cancer patients by delivering radiation directly to solid tumours while sparing healthy tissue.
Actithera
This biotechnology company develops targeted radioligand therapies to treat cancer patients by delivering radioactive isotopes directly to solid tumours.
Galera
This biopharmaceutical company develops small-molecule therapies to reduce the side effects of radiotherapy and improve treatment outcomes for patients with advanced breast cancer.
CollimateHealth
This company develops microbeam radiation technology for oncology clinics to treat cancer tumours through high-dose, narrow beams that activate immune responses.
Akiram Therapeutics
This biotech company develops targeted radiopharmaceuticals and radioimmunotherapies for patients with solid tumours and metastatic cancers.
Haptena Therapeutics
This biotechnology company develops immunotherapies for patients with oncogene-driven cancers by integrating precision oncology with immune engineering.
